S. Moroso

Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer

F. Puglisi, G. Aprile, M. Mazzer, 2009, Anti-cancer drugs.

Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients

A. Caraceni, S. Ricci, F. Masedu, 2018, Cancers.

Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis.

G. Fasola, F. Puglisi, G. Arpino, 2017, Breast.

The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.

S. Barni, L. Cavanna, F. Puglisi, 2019, Clinical breast cancer.

Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study

A. Caraceni, S. Ricci, F. Masedu, 2020, JCO precision oncology.

Risk factors and survival outcomes in patients with brain metastases from breast cancer

F. Puglisi, A. Minisini, M. Guardascione, 2013, Clinical & Experimental Metastasis.

Maintenance of clinical response after short treatment with cemiplimab for advanced squamous cell carcinoma

I. Zalaudek, M. Agozzino, D. Fedele, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)

E. Zecca, G. Fasola, A. Caraceni, 2016, Advances in Therapy.

Risk factors and survival outcomes in patients with brain metastases from breast cancer

G. Fasola, F. Puglisi, A. Minisini, 2013, Clinical & Experimental Metastasis.